BurstIQ, the leading provider of blockchain-based data exchange solutions, announced today that the company has entered into a research collaboration agreement with The National Center for Advancing Translational Sciences (NCATS).
Latest Press Releases
— Our press release programs work hand in hand with our SEO programs to provide a rock solid positioning in all major search engines so as to contemplate the visibility of your message for Worldwide Pharmaceutical industry.
CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company, announced that its ordinary shares have been approved for trading on the Nasdaq.
Vivera Pharmaceuticals, Inc. is pleased to announce the allowance of its dose-controlled drug delivery device patent for ZICOH®.
Gigajot Technology, inventors of the Quanta Image Sensor (QIS), today announced the first QIS products, marking the dawn of a new era in solid-state imaging.
Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, announced today that the Company’s scientific researchers, together with its joint research partners, Universities of Jaén and Granada.
HempFusion Wellness Inc. (TSX:CBD.U) (US:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness Company offering premium probiotic supplements and products containing.
Nanotechnology firm, IdentifySensors Biologics, in partnership with Purdue University, announced that it has completed development of an all-new diagnostic technology platform that detects numerous pathogens, including COVID-19, using electronic nanosensors.
Medical leverage (ml), a full-service medical communications agency, announces the launch of its mlCatalyst publication planning solution.
Inova Diagnostics, a world leader in autoimmune disease diagnostic systems and reagents for the clinical laboratory, is pleased to announce the Emergency Use Authorization of QUANTA Flash.
Nexturn Bio Inc., a subsidiary of Nexturn Bioscience Co., Ltd. (KOSDAQ:89140), has selected its first technological investment target to expand its new bio business.